Smithfield Trust’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-71
Closed -$2K 1020
2024
Q2
$2K Hold
71
﹤0.01% 969
2024
Q1
$2K Hold
71
﹤0.01% 996
2023
Q4
$2K Hold
71
﹤0.01% 978
2023
Q3
$2K Hold
71
﹤0.01% 971
2023
Q2
$2K Hold
71
﹤0.01% 985
2023
Q1
$2K Hold
71
﹤0.01% 953
2022
Q4
$2K Buy
+71
New +$2.25K ﹤0.01% 949

Other funds holding ARKG

Smithfield Trust's ARKG Position: Q3 2024 in Review

Smithfield Trust sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2024, closing a stake of 71 shares — an estimated $2K sold.

Smithfield Trust first reported a position in ARKG in Q4 2022 and held it in 7 quarters. The position peaked at $2K in Q2 2024. 238 funds tracked by Wall St. Rank hold ARKG as of Q3 2024.

  • Smithfield Trust reported no remaining ARK Genomic Revolution ETF position as of Q3 2024 after selling out during the quarter.
  • Smithfield Trust sold 71 ARK Genomic Revolution ETF shares in Q3 2024, an estimated $2K.
  • Smithfield Trust first reported a position in ARK Genomic Revolution ETF in Q4 2022 and held it in 7 quarters.
  • Smithfield Trust's ARK Genomic Revolution ETF position peaked at $2K in Q2 2024.
  • 238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2024.

Based on Smithfield Trust's 13F filing for Q3 2024, filed 12 Nov 2024.